Kenneth Calman: focusing on new priorities.
Calman was professor of oncology at Glasgow University. He is currently chancellor of the university and will take up his new role with the NCRI in addition to this post. “I’m joining the NCRI just as the organisation enters a new five year strategic plan,” said Calman. “Cancer research is a fast moving field and we will be focusing on new priorities – such as providing care and support for cancer survivors, and early detection and diagnosis. The strategic planning and coordination that the NCRI provides will be crucial in delivering on these.”
In total, NCRI partners have an annual spend on cancer research exceeding £400 million.
“We will help the funders understand the challenges of supporting research in these areas, and we will develop joint plans to promote and deliver this work,” said Calman.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.